Randomized Controlled Trial
. 2007 Oct 18;357(16):1579-88. doi: 10.1056/NEJMoa071430. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancerAffiliations
AffiliationItem in Clipboard
Randomized Controlled Trial
Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancerMarie-Hélène Mayrand et al. N Engl J Med. 2007.
Free article . 2007 Oct 18;357(16):1579-88. doi: 10.1056/NEJMoa071430. AffiliationItem in Clipboard
AbstractBackground: To determine whether testing for DNA of oncogenic human papillomaviruses (HPV) is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we conducted a randomized trial comparing the two methods.
Methods: We compared HPV testing, using an assay approved by the Food and Drug Administration, with conventional Pap testing as a screening method to identify high-grade cervical intraepithelial neoplasia in women ages 30 to 69 years in Montreal and St. John's, Canada. Women with abnormal Pap test results or a positive HPV test (at least 1 pg of high-risk HPV DNA per milliliter) underwent colposcopy and biopsy, as did a random sample of women with negative tests. Sensitivity and specificity estimates were corrected for verification bias.
Results: A total of 10,154 women were randomly assigned to testing. Both tests were performed on all women in a randomly assigned sequence at the same session. The sensitivity of HPV testing for cervical intraepithelial neoplasia of grade 2 or 3 was 94.6% (95% confidence interval [CI], 84.2 to 100), whereas the sensitivity of Pap testing was 55.4% (95% CI, 33.6 to 77.2; P=0.01). The specificity was 94.1% (95% CI, 93.4 to 94.8) for HPV testing and 96.8% (95% CI, 96.3 to 97.3; P<0.001) for Pap testing. Performance was unaffected by the sequence of the tests. The sensitivity of both tests used together was 100%, and the specificity was 92.5%. Triage procedures for Pap or HPV testing resulted in fewer referrals for colposcopy than did either test alone but were less sensitive. No adverse events were reported.
Conclusions: As compared with Pap testing, HPV testing has greater sensitivity for the detection of cervical intraepithelial neoplasia. (Current Controlled Trials number, ISRCTN57612064 [controlled-trials.com].).
Copyright 2007 Massachusetts Medical Society.
Similar articlesNaucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Johansson B, Forslund O, Hansson BG, Rylander E, Dillner J. Naucler P, et al. N Engl J Med. 2007 Oct 18;357(16):1589-97. doi: 10.1056/NEJMoa073204. N Engl J Med. 2007. PMID: 17942872 Clinical Trial.
Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA. Kulasingam SL, et al. JAMA. 2002 Oct 9;288(14):1749-57. doi: 10.1001/jama.288.14.1749. JAMA. 2002. PMID: 12365959
Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA. Manos MM, et al. JAMA. 1999 May 5;281(17):1605-10. doi: 10.1001/jama.281.17.1605. JAMA. 1999. PMID: 10235153
Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, Schünemann H, Paraskevaidis E, Arbyn M. Koliopoulos G, et al. Cochrane Database Syst Rev. 2017 Aug 10;8(8):CD008587. doi: 10.1002/14651858.CD008587.pub2. Cochrane Database Syst Rev. 2017. PMID: 28796882 Free PMC article. Review.
Rao R, Molina D, Halligan AM, Vakil B, Alperstein SA, Hoda RS. Rao R, et al. Diagn Cytopathol. 2015 Sep;43(9):763-9. doi: 10.1002/dc.23303. Epub 2015 Jul 15. Diagn Cytopathol. 2015. PMID: 26173579 Review.
Pedersen K, Burger EA, Sy S, Kristiansen IS, Kim JJ. Pedersen K, et al. Gynecol Oncol. 2016 Nov;143(2):326-333. doi: 10.1016/j.ygyno.2016.08.231. Epub 2016 Aug 17. Gynecol Oncol. 2016. PMID: 27542966 Free PMC article.
Bondagji NS, Gazzaz FS, Sait K, Abdullah L. Bondagji NS, et al. Ann Saudi Med. 2013 Jan-Feb;33(1):13-7. doi: 10.5144/0256-4947.2013.13. Ann Saudi Med. 2013. PMID: 23458934 Free PMC article.
Katki HA, Wentzensen N. Katki HA, et al. Lancet Oncol. 2012 Jan;13(1):8-10. doi: 10.1016/S1470-2045(11)70334-5. Epub 2011 Dec 14. Lancet Oncol. 2012. PMID: 22177578 Free PMC article. No abstract available.
Agorastos T, Chatzistamatiou K, Katsamagkas T, Koliopoulos G, Daponte A, Constantinidis T, Constantinidis TC; HERMES study group. Agorastos T, et al. PLoS One. 2015 Mar 20;10(3):e0119755. doi: 10.1371/journal.pone.0119755. eCollection 2015. PLoS One. 2015. PMID: 25793281 Free PMC article.
Du H, Qu X, Wang G, Guo C, Wang Z, Min J, Liu Z, Hu Q, Luo H, Wang C, Huang X, Chen Y, Wu B, Belinson JL, Wu R. Du H, et al. BMC Womens Health. 2023 Dec 1;23(1):641. doi: 10.1186/s12905-023-02733-1. BMC Womens Health. 2023. PMID: 38041116 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3